407 related articles for article (PubMed ID: 9084797)
1. Geographical distribution of HIV-1 group O viruses in Africa.
Peeters M; Gueye A; Mboup S; Bibollet-Ruche F; Ekaza E; Mulanga C; Ouedrago R; Gandji R; Mpele P; Dibanga G; Koumare B; Saidou M; Esu-Williams E; Lombart JP; Badombena W; Luo N; Vanden Haesevelde M; Delaporte E
AIDS; 1997 Mar; 11(4):493-8. PubMed ID: 9084797
[TBL] [Abstract][Full Text] [Related]
2. Antibodies to V3 loop peptides derived from chimpanzee lentiviruses and the divergent HIV-1ANT-70 isolate in human sera from different geographic regions.
Peeters M; Nkengasong J; Willems B; Karita E; Delaporte E; Van den Haesevelde M; Piot P; van der Groen G
AIDS; 1994 Dec; 8(12):1657-61. PubMed ID: 7888113
[TBL] [Abstract][Full Text] [Related]
3. A survey of synthetic HIV-1 peptides with natural and chimeric sequences for differential reactivity with Zimbabwean, Tanzanian and Swedish HIV-1-positive sera.
Blomberg J; Lawoko A; Pipkorn R; Moyo S; Malmvall BE; Shao J; Dash R; Tswana S
AIDS; 1993 Jun; 7(6):759-67. PubMed ID: 8363754
[TBL] [Abstract][Full Text] [Related]
4. Evidence of no change in V3 loop antibody recognition pattern in HIV type 1-infected Ethiopians between 1988 and 1993.
Sherefa K; Sällberg M; Sönnerborg A
AIDS Res Hum Retroviruses; 1994 Nov; 10(11):1551-6. PubMed ID: 7534097
[TBL] [Abstract][Full Text] [Related]
5. Envelope sequence variability and serologic characterization of HIV type 1 group O isolates from equatorial guinea.
Hunt JC; Golden AM; Lund JK; Gürtler LG; Zekeng L; Obiang J; Kaptué L; Hampl H; Vallari A; Devare SG
AIDS Res Hum Retroviruses; 1997 Aug; 13(12):995-1005. PubMed ID: 9264286
[TBL] [Abstract][Full Text] [Related]
6. Relative reactivity of the V3 loop PND of HIV-1 subtypes A, B, C, D, and F with sera from selected Ugandan localities.
Riley JP; Pestano GA; Hosford K; Francis C; Xie JM; Mugyenyi P; Kataaha P; Katongole-Mbidde E; Anokbonggo WW; Guyden J
Arch Virol; 1995; 140(8):1393-404. PubMed ID: 7544970
[TBL] [Abstract][Full Text] [Related]
7. High prevalence of antibodies to the gp120 V3 region principal neutralizing determinant of HIV-1MN in sera from Africa and the Americas.
Carrow EW; Vujcic LK; Glass WL; Seamon KB; Rastogi SC; Hendry RM; Boulos R; Nzila N; Quinnan GV
AIDS Res Hum Retroviruses; 1991 Oct; 7(10):831-8. PubMed ID: 1720630
[TBL] [Abstract][Full Text] [Related]
8. Epidemiological and molecular characteristics of HIV infection in Gabon, 1986-1994.
Delaporte E; Janssens W; Peeters M; Buvé A; Dibanga G; Perret JL; Ditsambou V; Mba JR; Courbot MC; Georges A; Bourgeois A; Samb B; Henzel D; Heyndrickx L; Fransen K; van der Groen G; Larouzé B
AIDS; 1996 Jul; 10(8):903-10. PubMed ID: 8828748
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of different V3 peptides in an enzyme immunoassay for specific HIV type 1 group O antibody detection.
Ondoa P; Willems B; Fransen K; Nkengasong J; Janssens W; Heyndrickx L; Zekeng L; Ndumbe P; Simon F; Saragosti S; Gürtler L; Peeters M; Korber B; Goudsmit J; van der Groen G
AIDS Res Hum Retroviruses; 1998 Jul; 14(11):963-72. PubMed ID: 9686642
[TBL] [Abstract][Full Text] [Related]
10. Reactions of Ugandan antisera with peptides encoded by V3 loop epitopes of human immunodeficiency virus type 1.
Smith JD; Bruce CB; Featherstone AS; Downing RG; Biryahawaho B; Clegg JC; Carswell JW; Oram JD
AIDS Res Hum Retroviruses; 1994 May; 10(5):577-83. PubMed ID: 7522494
[TBL] [Abstract][Full Text] [Related]
11. Field evaluation of alternative testing strategies for diagnosis and differentiation of HIV-1 and HIV-2 infections in an HIV-1 and HIV-2-prevalent area.
Andersson S; da Silva Z; Norrgren H; Dias F; Biberfeld G
AIDS; 1997 Dec; 11(15):1815-22. PubMed ID: 9412699
[TBL] [Abstract][Full Text] [Related]
12. Examination of sera from human immunodeficiency virus type 1 (HIV-1)-infected individuals for antibodies reactive with peptides corresponding to the principal neutralizing determinant of HIV-1 gp120 and for in vitro neutralizing activity.
Warren RQ; Anderson SA; Nkya WM; Shao JF; Hendrix CW; Melcher GP; Redfield RR; Kennedy RC
J Virol; 1992 Sep; 66(9):5210-5. PubMed ID: 1380094
[TBL] [Abstract][Full Text] [Related]
13. [Experience of the National HIV-AIDS Reference Center of Turkey, in the Transition to the New HIV Diagnostic Algorithm; Comparative Analysis of Line-Immunoassay Test and Bio-Rad Geenius™ HIV-1/2 Antibody Confirmatory Assay].
Demir T; Yıldıran D; Kılıç S
Mikrobiyol Bul; 2021 Jan; 55(1):17-29. PubMed ID: 33590978
[TBL] [Abstract][Full Text] [Related]
14. Serological and virological characterization of HIV-1 group O infection in Cameroon.
Mauclère P; Loussert-Ajaka I; Damond F; Fagot P; Souquières S; Monny Lobe M; Mbopi Keou FX; Barré-Sinoussi F; Saragosti S; Brun-Vézinet F; Simon F
AIDS; 1997 Mar; 11(4):445-53. PubMed ID: 9084791
[TBL] [Abstract][Full Text] [Related]
15. Highly specific V3 peptide enzyme immunoassay for serotyping HIV-1 specimens from Thailand.
Pau CP; Lee-Thomas S; Auwanit W; George JR; Ou CY; Parekh BS; Granade TC; Holloman DL; Phillips S; Schochetman G
AIDS; 1993 Mar; 7(3):337-40. PubMed ID: 8471195
[TBL] [Abstract][Full Text] [Related]
16. Synthetic peptide strategy for the detection of and discrimination among highly divergent primate lentiviruses.
Simon F; Souquière S; Damond F; Kfutwah A; Makuwa M; Leroy E; Rouquet P; Berthier JL; Rigoulet J; Lecu A; Telfer PT; Pandrea I; Plantier JC; Barré-Sinoussi F; Roques P; Müller-Trutwin MC; Apetrei C
AIDS Res Hum Retroviruses; 2001 Jul; 17(10):937-52. PubMed ID: 11461679
[TBL] [Abstract][Full Text] [Related]
17. HIV-2 infection in Denmark.
Kvinesdal BB; Worm AM; Lindhardt BO; Jensen BL; Nielsen CM; Poulsen AG
Scand J Infect Dis; 1992; 24(4):419-21. PubMed ID: 1411306
[TBL] [Abstract][Full Text] [Related]
18. Rapid and simple screening and supplemental testing for HIV-1 and HIV-2 infections in west Africa.
Brattegaard K; Kouadio J; Adom ML; Doorly R; George JR; De Cock KM
AIDS; 1993 Jun; 7(6):883-5. PubMed ID: 8395857
[TBL] [Abstract][Full Text] [Related]
19. Peptide serology for analysis of the inter- and intra-individual variation in the HIV-1 V3 domain.
Jansson M; Wahren B; Albert J; Scarlatti G; Franzén L; Kataaha PK; Katabira E; Mubiro F; Wigzell H; Rossi P
AIDS; 1994 Apr; 8(4):413-21. PubMed ID: 8011244
[TBL] [Abstract][Full Text] [Related]
20. Simultaneous introduction of distinct HIV-1 subtypes into different risk groups in Russia, Byelorussia and Lithuania.
Lukashov VV; Cornelissen MT; Goudsmit J; Papuashvilli MN; Rytik PG; Khaitov RM; Karamov EV; de Wolf F
AIDS; 1995 May; 9(5):435-9. PubMed ID: 7639968
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
